Sangamo Therapeutics, Inc
SGMOQ· OTC
SGMOQSangamo Therapeutics, Inc
Who holds Sangamo Therapeutics, Inc, from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Nomura Asset Management International Inc. | 400K | ±0% | $22K | 0% | Aug 14, 2026 |
| Simplex Trading, LLC | 76.5K | New | $4.1K | 0% | Aug 12, 2026 |
| Axiom Investment Management LLC | 25.4K | ±0% | $1.4K | 0.1% | Jul 31, 2026 |
| Heritage Investment Group, Inc. | 10K | New | $539 | 0.1% | Jul 29, 2026 |
| Flow Traders U.S. LLC | 21.5K | +0.2% | $1 | 0% | Aug 14, 2026 |
| Barclays PLC | 1 | ±0% | $0 | 0% | Aug 14, 2026 |
